Metrics, a subsidiary of Mayne Pharma Group Limited, is a full-service global contract development and manufacturing organization (CDMO) specializing in oral and topical dosage forms. Additionally, the company offers clients a portfolio of advanced proprietary delivery methods for controlled release, bioavailability enhancement and taste masking. Metrics offers particular expertise in First-Time-In-Man (FTIM) and Phase I, II, and III Clinical Trial Manufacturing (CTM). Globally, the company provides its contract services to support investigational new drug (IND), new drug (NDA), and abbreviated new drug (ANDA) submissions to regulatory agencies.